Comprehensive wastewater treatment method for bismuth pectin bulk drug, acridone acetic acid, acyclovir and thiodipropionate medical intermediate

A technology of thiodipropionate and acridone acetic acid is applied in the fields of bismuth pectin raw material medicine, thiodipropionate pharmaceutical intermediate comprehensive wastewater treatment, acridone acetic acid and acyclovir, and can solve the problem. The problems of large salt content, high concentration, and large changes in water quality and quantity have achieved the effects of huge social and economic benefits, reduced pollutant concentration, and convenient operation and management.

Inactive Publication Date: 2020-07-31
HENAN HENGAN ENVIRONMENTAL PROTECTION TECHCO LTD
View PDF11 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Chemical synthetic drug production wastewater is characterized by high chemical oxygen demand (COD), low biological oxygen demand (BOD), and high salt content. It varies greatly, and most of them contain refractory biodegradable substances and microbial growth inhibitors. Among the five types of wastewater discharged from the pharmaceutical industry, chemical synthesis drug production wastewater is currently the most polluted and also the most difficult to treat. The characteristics of the wastewater quality ar

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Comprehensive wastewater treatment method for bismuth pectin bulk drug, acridone acetic acid, acyclovir and thiodipropionate medical intermediate
  • Comprehensive wastewater treatment method for bismuth pectin bulk drug, acridone acetic acid, acyclovir and thiodipropionate medical intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0020] The specific implementation of the present invention will be described in detail below in conjunction with the accompanying drawings and specific conditions.

[0021] When the present invention is implemented, it is provided by the following examples.

[0022] A kind of pectin bismuth crude drug, acridone acetic acid and acyclovir, thiodipropionate pharmaceutical intermediate comprehensive waste water treatment method, comprises the following steps:

[0023] 1) Wastewater desalination: high-salt wastewater is desalinated through evaporator 1, and the treated condensed water enters the grid channel 2 after being mixed with non-high-salt raw water to remove large suspended matter, floating matter, fibrous matter and solid particles in the sewage substances, so as to ensure the normal operation of subsequent processing structures and reduce the processing load of subsequent processing structures;

[0024] 2) Regulating the pH of wastewater: Many of the raw materials of bi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a comprehensive wastewater treatment method for bismuth pectin bulk drugs, acridone acetic acid, acyclovir and thiodipropionate medical intermediates. The method comprises thefollowing steps: 1) performing wastewater desalination; 2) adjusting the pH of the wastewater; 3) carrying out pH acidification treatment on the wastewater; (4) carrying out Fenton reaction; 5) performing wastewater pH back-regulation treatment; 6) performing hydrolytic acidification of the wastewater; 7) performing anaerobic treatment on the wastewater; 8) performing AO reaction; 9) performing secondary precipitation; 10) flocculating and precipitating: adding 10% by mass of PAC and 0.1% by mass of PAM into a flocculation sedimentation tank; enabling the wastewater to react for 0.5 to 1h ina flocculation sedimentation tank; allowing part of sludge generated in the reaction process to flow back to the anoxic tank, enabling residual sludge to enter a sludge tank, and discharging supernatethrough a wastewater up-to-standard discharge pipeline; according to the present invention, the method has characteristics of low cost, convenient operation management, reduced wastewater pollutant concentration, and thus further reaching treatment standard, effective removing COD, BOD and NH3-N, achieving discharge standard, and providing huge social and economic benefits.

Description

technical field [0001] The invention relates to waste water treatment, in particular to a comprehensive waste water treatment method for pectin bismuth raw materials, acridone acetic acid, acyclovir and thiodipropionate pharmaceutical intermediates. Background technique [0002] Chemical synthetic drug production wastewater is characterized by high chemical oxygen demand (COD), low biological oxygen demand (BOD), and high salt content. Among the five types of wastewater discharged from the pharmaceutical industry, chemical synthesis drug production wastewater is currently the most polluted and also the most difficult to treat. The characteristics of the wastewater quality are: : ① special pollutants: aniline; conventional pollutants, namely COD, BOD, suspended solids (SS), chroma, ammonia nitrogen and other pollutants; ② poor biodegradability; ③ waste water contains residual products, reactants, catalysts , solvents, etc., BOD, COD and total suspended solids (TSS) concentra...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C02F9/14C02F103/34
CPCC02F9/00C02F2103/343C02F1/048C02F1/001C02F1/66C02F1/722C02F2305/026C02F3/34C02F3/302C02F1/52C02F1/5245C02F1/56C02F1/5281C02F2301/08C02F2203/006C02F2301/046C02F2209/08C02F2209/06C02F2209/14C02F2209/16C02F2209/10
Inventor 陈新强马三贵钮劲涛彭学辉赵涛刘强王亚飞李世新金宝丹
Owner HENAN HENGAN ENVIRONMENTAL PROTECTION TECHCO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products